VAI-SU2C Epigenetics Dream Team
35 results.
LOS ANGELES (June 5, 2018) — The entertainment community is coming together for Stand Up To Cancer (SU2C) and its sixth biennial roadblock televised fundraising special,…
Four years ago, we embarked on a collaborative endeavor to improve cancer treatment by establishing the Van Andel Research Institute–Stand Up To Cancer (VARI–SU2C) Epigenetics…
With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…
A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other cancer type and…
Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr. Steve Baylin Co-leaders,…
GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team (VARI-SU2C) scientists have been awarded two…
GRAND RAPIDS, Mich. (June 13, 2017)—A new clinical trial spanning three cancer centers in California, Maryland and Pennsylvania is investigating a promising…
VARI-affiliated cancer researcher Stephen Baylin, M.D., has been elected to the National Academy of Sciences…